Obesity Trial, Recruiting (NCT06278285)

Obesity Trial, Recruiting NCT06278285 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06278285 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who are able to read and understand the study information and consent form
People with a BMI over 35 who also have at least one other related health condition, or people with a BMI over 40
People whose case for weight-loss digestive surgery has been approved through a specialist multidisciplinary team meeting and by the relevant health insurance authority (CPAM)
People who are members of a social security scheme in France
People who have given their signed agreement to participate in the study
For the GLP-1 medication group: people who have been taking a GLP-1 analogue medication for at least 3 months
For the comparison group: people who have never taken a GLP-1 analogue medication

Who may not be able to join:

Women who are pregnant or currently breastfeeding
People who are under legal guardianship or considered legally vulnerable
People who are currently deprived of their liberty (for example, those who are incarcerated)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Iannelli Antonio, PhD, Clinique Parc Impérial, Service de Chirurgie Digestive

Phone: +3349209220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06278285

Sponsor: Centre Hospitalier Universitaire de Nice

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: +3349209220

More information: https://clinicaltrials.gov/study/NCT06278285

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who are able to read and understand the study information and consent form
People with a BMI over 35 who also have at least one other related health condition, or people with a BMI over 40
People whose case for weight-loss digestive surgery has been approved through a specialist multidisciplinary team meeting and by the relevant health insurance authority (CPAM)
People who are members of a social security scheme in France
People who have given their signed agreement to participate in the study
For the GLP-1 medication group: people who have been taking a GLP-1 analogue medication for at least 3 months
For the comparison group: people who have never taken a GLP-1 analogue medication

Who may not be able to join:

Women who are pregnant or currently breastfeeding
People who are under legal guardianship or considered legally vulnerable
People who are currently deprived of their liberty (for example, those who are incarcerated)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Nice

Registry

ClinicalTrials.gov

Start date

6 March 2024

Est. completion

6 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of oxytocin

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov